Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
29.93
+0.12 (0.40%)
Dec 27, 2024, 9:44 AM EST - Market open

Alkermes Revenue

Alkermes had revenue of $378.14M in the quarter ending September 30, 2024, a decrease of -0.73%. This brings the company's revenue in the last twelve months to $1.51B, down -5.37% year-over-year. In the year 2023, Alkermes had annual revenue of $1.66B with 49.61% growth.

Revenue (ttm)
$1.51B
Revenue Growth
-5.37%
P/S Ratio
3.30
Revenue / Employee
$716,724
Employees
2,100
Market Cap
4.84B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.66B551.61M49.61%
Dec 31, 20221.11B-61.96M-5.28%
Dec 31, 20211.17B134.99M13.00%
Dec 31, 20201.04B-132.19M-11.29%
Dec 31, 20191.17B76.67M7.01%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
RadNet 1.77B
Integer Holdings 1.71B
Tempus AI 640.44M
Telix Pharmaceuticals 430.80M
TG Therapeutics 264.79M
Krystal Biotech 241.52M
BridgeBio Pharma 217.77M
PROCEPT BioRobotics 199.84M
Revenue Rankings